<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36566741</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Respiration; international review of thoracic diseases</Title><ISOAbbreviation>Respiration</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study.</ArticleTitle><Pagination><StartPage>120</StartPage><EndPage>133</EndPage><MedlinePgn>120-133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000528611</ELocationID><Abstract><AbstractText Label="BACKGROUND">Lung function impairment persists in some patients for months after acute coronavirus disease 2019 (COVID-19). Long-term lung function, radiological features, and their association remain to be clarified.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to prospectively investigate lung function and radiological abnormalities over 12 months after severe and non-severe COVID-19.</AbstractText><AbstractText Label="METHODS">584 patients were included in the Swiss COVID-19 lung study. We assessed lung function at 3, 6, and 12 months after acute COVID-19 and compared chest computed tomography (CT) imaging to lung functional abnormalities.</AbstractText><AbstractText Label="RESULTS">At 12 months, diffusion capacity for carbon monoxide (DLCOcorr) was lower after severe COVID-19 compared to non-severe COVID-19 (74.9% vs. 85.2% predicted, p &lt; 0.001). Similarly, minimal oxygen saturation on 6-min walk test and total lung capacity were lower after severe COVID-19 (89.6% vs. 92.2%, p = 0.004, respectively, 88.2% vs. 95.1% predicted, p = 0.011). The difference for forced vital capacity (91.6% vs. 96.3% predicted, p = 0.082) was not statistically significant. Between 3 and 12 months, lung function improved in both groups and differences in DLCO between non-severe and severe COVID-19 patients decreased. In patients with chest CT scans at 12 months, we observed a correlation between radiological abnormalities and reduced lung function. While the overall extent of radiological abnormalities diminished over time, the frequency of mosaic attenuation and curvilinear patterns increased.</AbstractText><AbstractText Label="CONCLUSIONS">In this prospective cohort study, patients who had severe COVID-19 had diminished lung function over the first year compared to those after non-severe COVID-19, albeit with a greater extent of recovery in the severe disease group.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lenoir</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland, amihalache7@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gesundheitsamt F&#xfc;rstenfeldbruck, F&#xfc;rstenfeldbruck, Germany, amihalache7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christe</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Diagnostic, Interventional and Paediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebner</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Diagnostic, Interventional and Paediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beigelman-Aubry</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Radiodiagnostic and Interventional Radiology, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bridevaux</LastName><ForeName>Pierre-Olivier</ForeName><Initials>PO</Initials><AffiliationInfo><Affiliation>Service de Pneumologie, H&#xf4;pital du Valais, Sion, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brutsche</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lung Center, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarenbach</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pulmonary Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erkosar</LastName><ForeName>Berra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garzoni</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geiser</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research, Department of Pulmonary Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guler</LastName><ForeName>Sabina A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research, Department of Pulmonary Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heg</LastName><ForeName>Dik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CTU Bern, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lador</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancinetti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University and Hospital of Fribourg, Villars-sur-Gl&#xe2;ne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Sebastian R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, St. Claraspital AG, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piquilloud</LastName><ForeName>Lise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Adult Intensive Care Unit, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prella</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Que</LastName><ForeName>Yok-Ai</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Garnier</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funke-Chambour</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for BioMedical Research, Department of Pulmonary Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Respiration</MedlineTA><NlmUniqueID>0137356</NlmUniqueID><ISSNLinking>0025-7931</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 sequelae</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 lung functional sequelae</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 radiological sequelae</Keyword></KeywordList><CoiStatement>Christian Clarenbach received advisory fees from Roche, Novartis, Boehringer, GSK, AstraZeneca, Sanofi, Vifor, OM Pharma, Grifols, and Mundipharma within the last 36 months. Christophe von Garnier obtained advisory fees from AstraZeneca, Boehringer Ingelheim, GSK, Mundipharma, Novartis, OM Pharma, Pfizer, PneumRx and Pulmonx, and Sanofi and received financial support from the Ligue pulmonaire vaudoise, the Yuchum Foundation, and the Placide Nicod Foundation. Manuela Funke-Chambour has received research funding from Boehringer Ingelheim and Roche and advisory fees from Boehringer Ingelheim, MSD, Daiichi Sankyo, and Novartis unrelated to the presented study. Marco Mancinetti received financial support from the University and Hospital of Fribourg, Switzerland, to cover protected time for clinical research. Lise Piquilloud obtained lecture fees for conferences given in scientific symposium for different ventilator manufacturers (Getinge, Hamilton, General Electrics, Fisher, and Paykel). Sebastian Ott is supported by the Lungenliga beider Basel. Sebastian Ott received consulting fees from GSK and honoraria from Novartis and participated in advisory boards for GSK, Boehringer Ingelheim, and Novartis.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>25</Day><Hour>18</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36566741</ArticleId><ArticleId IdType="pmc">PMC9932828</ArticleId><ArticleId IdType="doi">10.1159/000528611</ArticleId><ArticleId IdType="pii">000528611</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19 a longitudinal cohort study. Lancet. 2021 Aug 28;398((10302)):747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun;55((6)):2001217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19 a systematic review and meta-analysis. Pulmonology. 2020 Nov 25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features four months after COVID-19 first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021 Jan 8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasio F, Barbuto S, Scarnecchia E, Cosma P, Fugagnoli A, Rossi G, et al. Medium-term impact of COVID-19 on pulmonary function functional capacity and quality of life. Eur Respir J. 2021 Feb 11;58((3)):2004015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021 Jan 4;4((1)):e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021 Apr;299((1)):E177&#x2013;E186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Safont B, Tarraso J, Rodriguez-Borja E, Fernandez-Fabrellas E, Sancho-Chust JN, Molina V, et al. Lung function, radiological findings and biomarkers of fibrogenesis in a cohort of COVID-19 patients six months after hospital discharge. Arch Bronconeumol. 2021 Sep 3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414844</ArticleId><ArticleId IdType="pubmed">34497426</ArticleId></ArticleIdList></Reference><Reference><Citation>Stylemans D, Smet J, Hanon S, Schuermans D, Ilsen B, Vandemeulebroucke J, et al. Evolution of lung function and chest CT 6 months after COVID-19 pneumonia real-life data from a Belgian University Hospital. Respir Med. 2021 Jun;182:106421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053365</ArticleId><ArticleId IdType="pubmed">33901788</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation a prospective study. Lancet Respir Med. 2021 May 5;9((7)):747&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AU, Devaraj A, Desai SR. Interstitial lung disease after COVID-19 infection a catalog of uncertainties. Radiology. 2021 Apr;299((1)):E216&#x2013;E218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841875</ArticleId><ArticleId IdType="pubmed">33502279</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke-Chambour M, Bridevaux PO, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C, et al. Swiss recommendations for the follow-up and treatment of pulmonary long COVID Respiration. 2021 Jun 4;100((8)):826&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339046</ArticleId><ArticleId IdType="pubmed">34091456</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017 Jan;49((1)):1600016.</Citation><ArticleIdList><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019 Oct 15;200((8)):e70&#x2013;e88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44((6)):1428&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec;30((12)):6808&#x2013;6817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334627</ArticleId><ArticleId IdType="pubmed">32623505</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntley CC, Patel K, Bil Bushra SES, Mobeen F, Armitage MN, Pye A, et al. Pulmonary function test and computed tomography features during follow-up after SARS MERS and COVID-19 a systematic review and meta-analysis. ERJ Open Res. 2022 Apr;8((2)):00056&#x2013;2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9035766</ArticleId><ArticleId IdType="pubmed">35642193</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y, et al. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. 2020 Dec 7;35((47)):e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez J, Benitez ID, Carmona P, Santisteve S, Monge A, Moncusi-Moix A, et al. Pulmonary function and radiologic features in survivors of critical COVID-19 a 3-month prospective cohort. Chest. 2021 Jul;160((1)):187&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, Aalokken TM, Bronstad E, Aarli B, Ikdahl E, Lund KMA, et al. Dyspnoea lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021 Apr;57((4)):2003448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021 Jul;58((1)):2003677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Tymoszuk P, Sahanic S, Boehm A, Pizzini A, Luger A, et al. Investigating phenotypes of pulmonary COVID-19 recovery a longitudinal observational prospective multicenter trial. Elife. 2022 Feb 8;11:e72500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896831</ArticleId><ArticleId IdType="pubmed">35131031</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19 a longitudinal cohort study. Lancet Respir Med. 2022 May 11;10((9)):863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society glossary of terms for thoracic imaging. Radiology. 2008 Mar;246((3)):697&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pubmed">18195376</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021 Jan;27((1)):28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, Villacreses R, Nagpal P, Guo J, Pezzulo AA, Thurman AL, et al. Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology. 2022 Mar 15;304((1)):185&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieco DL, Bongiovanni F, Chen L, Menga LS, Cutuli SL, Pintaudi G, et al. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies. Crit Care. 2020 Aug 28;24((1)):529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453378</ArticleId><ArticleId IdType="pubmed">32859264</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, et al. Beyond the clot perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021 Jan;9((1)):107&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020 Aug;58:102925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397705</ArticleId><ArticleId IdType="pubmed">32745993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketai L, Paul NS, Wong Kt T. Radiology of severe acute respiratory syndrome (SARS) the emerging pathologic-radiologic correlates of an emerging disease. J Thorac Imaging. 2006 Nov;21((4)):276&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">17110851</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt CE, Combes A, Becquemin MH, Beigelman-Aubry C, Hatem S, Brun AL, et al. Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest. 2012 Sep;142((3)):583&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pubmed">22948576</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology perspective of coronavirus disease 2019 (COVID-19) lessons from severe acute respiratory syndrome and Middle East respiratory syndrome. AJR Am J Roentgenol. 2020 May;214((5)):1078&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">32108495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebner L, Funke-Chambour M, von Garnier C, Ferretti G, Ghaye B, Beigelman-Aubry C. Imaging in the aftermath of COVID-19 what to expect. Eur Radiol. 2021 Jun;31((6)):4390&#x2013;4392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769564</ArticleId><ArticleId IdType="pubmed">33372242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ujita M, Renzoni EA, Veeraraghavan S, Wells AU, Hansell DM. Organizing pneumonia perilobular pattern at thin-section CT. Radiology. 2004 Sep;232((3)):757&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">15229349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006 Aug;28((2)):422&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">16880372</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021 May;18((5)):799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>